Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway. [electronic resource]
Producer: 20170104Description: 20500 p. digitalISSN:- 2045-2322
- Antineoplastic Agents -- pharmacology
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Cell Line, Tumor
- Cell Movement -- drug effects
- Colonic Neoplasms -- drug therapy
- Dose-Response Relationship, Drug
- Epithelial-Mesenchymal Transition -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- HT29 Cells
- Humans
- MAP Kinase Signaling System -- drug effects
- Proto-Oncogene Protein c-ets-1 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.